Asciminib as a new option in the treatment of chronic myeloid leukemia
Abstract
Future OncologyVol. 17, No. 36 EditorialAsciminib as a new option in the treatment of chronic myeloid leukemiaBetül İbiş, Mario Tiribelli & Ahmet Emre EşkazanBetül İbiş https://orcid.org/0000-0002-6148-6177Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, TurkeySearch for more papers by this author, Mario Tiribelli https://orcid.org/0000-0001-9449-2621Division of Hematology and Blood and Marrow Transplantation, Department...
Paper Details
Title
Asciminib as a new option in the treatment of chronic myeloid leukemia
Published Date
Dec 1, 2021
Journal
Volume
17
Issue
36
Pages
5003 - 5005
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History